BELSOMRA WITHDRAWAL AND TAPERING HELP
Belsomra is the trade name for Suvorexant, produced by Merck Pharmaceutical and approved by the FDA in 2014 for the treatment of insomnia. The most common Belsomra Side Effects include nightmares, sleep terror or abnormal dreams, issues with sleepiness the following day that impairs driving. A small minority experienced a more awake state from Belsomra or thoughts of suicide. Although Belsomra was initially marketed as nonaddictive, Withdrawal Symptoms from Belsomra have proven to include dizziness, abnormal dreams, diarrhea, dry mouth, cough, anxiety and severe headaches. Weaning off Belsomra minimizes the Belsomra Withdrawal Symptoms yet many find that even a slow taper can be challenging unless the nervous system is calmed throughout the process. Point of Return has been helping people safely withdraw from sleeping pills in 78 countries over the past 15 years and utilize non-addictive and calming nutraceuticals to help ease Belsomra Withdrawal.* If you are looking for Help to Get Off Belsomra, CONTACT the Prescription Drug Experts for help!
Our Belsomra Taper program implements slow reduction schedules while utilizing specifically designed nutraceuticals to help meet the body's extreme and unique nutritional needs during an Belsomra taper. Our Belsomra weaning program is a slow taper that allows you to come off Belsomra under the guidance of Our Team; Your Physician and Pharmacist. The Pre-Taper is for Symptom Relief. You will not wean Belsomra until you feel better. This is where our Advanced Nutraceuticals are critical. Point of Return provides healthy, Drug-Free Strategies to help minimize Belsomra withdrawal to support well-being.*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our In-Home programs are individualized based on your situation. An assessment is done once you start the Belsomra Withdrawal Program which allows us to individualize your gameplan based on age; length of time on the medications; health challenges; lifestyle, stress levels; additional medications; goals; and interactions. Don't Wean Belsomra alone, work with our Prescription Drug Experts.*
Imagine being Free of Belsomra Dependency
- Proven Program completed At-Home with Expert Guidance
- Slowly Wean off Belsomra
- Nutraceuticals to help meet the body's unique nutritional needs during an Belsomra Withdrawal*
- Professional information on interactions
- Free Mentoring on our 24/7 Private Discussion Board
- Free Assessment Upon Starting our Program (a $400 value)
Enter Discount Code SleepingPillFree for FREE Ground Shipping on your Withdrawal Program *USA & Canada Only 866-605-2333
BELSOMRA HISTORY AND INFORMATION
Suvorexant, sold under the trade name Belsomra, is prescribed for insomnia and approved by the FDA in 2014. Belsomra may lead to physical dependence similar to that of sleeping pills or benzodiazepines, also Schedule IV medications. Some patients have worsening sleep disturbances with Belsomra, this may include nightmares, sleep tremors or abnormal dreams, with daytime impairment.
It is unclear if this medication is safe for people that have a history of addiction, since this subgroup was excluded from the clinical
trials of Belsomra. Also it is unclear how this medication compares to other sleeping pills since no comparison studies were done.
BELSOMRA WITHDRAWAL SYMPTOMS, SIDE EFFECTS, ADVERSE REACTIONS
BELSOMRA WITHDRAWAL SYMPTOMS MAY INCLUDE:
abdominal pains, aching, agoraphobia, anxiety, blurred vision, body vibrations, changes in perception, diarrhea, distended abdomen, feeling of unreality, flu-like symptoms, flatulence, food cravings, hair loss, heart palpitations, heavy limbs, increased allergies, increased sense of smell, insomnia, lethargy, loss of balance, metallic taste, muscle spasms, nightmares, panic attacks, paranoia, persistent & unpleasant memories, severe headaches, shaking, short term memory loss, sore mouth and tongue, sound & light sensitivity, speech difficulties, sweating, suicidal thoughts, tinnitus, unusually sensitive, fear.
BELSOMRA SIDE EFFECTS MAY INCLUDE:
temporary weakness in your legs, inability to move or talk up to several minutes, drowsiness during the day, memory loss, mood/behavior changes such; as anxiety, confusion, agitation, depression, thoughts of suicide, hallucinations, fear, unusual or abnormal dreams, lack of appetite, loss of interest, tiredness, trouble concentrating, sleepiness during the day, anxiety, confusion, more outgoing or aggressive behavior, leg weakness, sleep-walking activities including eating, talking, having sex or driving a car
Behavioral changes, depression, suicida ideation
Because sleep disturbances may be the presenting manifestation of a physical and/or psychiatric disorder, treatment of insomnia with suvorexant should be initiated only after careful evaluation of the patient. The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated. Worsening of insomnia or the emergence of new cognitive or behavioral changes may be the result of an unrecognized underlying psychiatric or physical disorder, and can emerge during the course of treatment with hypnotic drugs such as suvorexant. A variety of cognitive and behavioral changes (e.g., amnesia, anxiety, hallucinations and other neuro-psychiatric symptoms) have been reported to occur in association with the use of hypnotics such as suvorexant. In clinical studies, a dose-dependent increase in suicidal ideation was observed in patients taking suvorexant as assessed by questionnaire. Immediately evaluate patients with suicidal ideation or any new behavioral sign or symptom. In primarily depressed patients treated with sedative-hypnotics, worsening of depression, and suicidal thoughts and actions (including completed suicides) have been reported. Suicidal tendencies may be present in such patients and protective measures may be required. Intentional overdose is more common in this group of patients. Suvorexant should be prescribed in the smallest quantity consistent with good patient management to reduce the risk of overdose.
BELSOMRA PRECAUTIONS: continued
Coadministration with other CNS depressants, complex sleep-related behaviors, driving or operating machinery, ethanol ingestion
Chronic obstructive pulmonary disease (COPD), pulmonary disease, respiratory depression, sleep apnea
Alcoholism, substance abuse
BELSOMRA ADVERSE REACTIONS: per PDR
memory impairment, depression, amnesia, complex sleep-related behaviors, cataplexy, myasthenia, sleep paralysis, hallucinations, palpitations, sinus tachycardia, psychological dependence
drowsiness, headache, dizziness, abnormal dreams, xerostomia, diarrhea, infection, cough, hyperactivity, anxiety
BELSOMRA REFERENCES AND OTHER INFO
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with your physician to help you with your drug withdrawal process and with his or her consent.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More...